Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Point of Care Coagulation Testing in Patients Undergoing Major Surgery (POC-OP)

7. september 2015 oppdatert av: University of Bern

Does Point of Care Coagulation Testing Reduce the Transfusion of Non-erythrocyte Blood Products in Patients Undergoing Major Surgery? A Randomized-Controlled Trial

Bleeding is a frequent complication during surgery. The peri-operative administration of blood products, including packed red blood cells, thrombocytes and fresh frozen plasma (FFP), is often deemed necessary. Therefore the transfusion of allogenic blood products mandates strategies to optimize the clinical decision to transfuse. The decision to administer FFP is usually made in the absence of any data. Point of care testing of prothrombin time ensures that a major parameter of coagulation is readily available. The test is fast, easy to perform, inexpensive and may enable physicians to rationally determine the need for FFP. Objective of the study is to determine the effectiveness of point of care coagulation testing of prothrombin time to reduce the administration of FFP.

Studieoversikt

Detaljert beskrivelse

Background: Bleeding is a frequent complication during surgery. The peri-operative administration of blood products, including packed red blood cells, thrombocytes and fresh frozen plasma (FFP), is often deemed necessary. Beside the expenses of blood products these products carry risks of infection, allergic reaction and immune-modulation. Therefore the transfusion of allogenic blood products mandates strategies to optimize the clinical decision to transfuse. Bleeding during surgery is a dynamic process; it can happen within minutes and result not only in major blood loss, but also in coagulation aberrations. The indication for a transfusion should be based on reliable coagulation studies. Traditional coagulation studies require up to 1 hour. Therefore, the decision to administer FFP is usually made in the absence of any data. Point of care testing of prothrombin time ensures that a major parameter of coagulation is readily available in the operation theatre within 3 minutes. It is fast, easy to perform, inexpensive and may enable physicians to rationally determine the need for FFP. Objective: To determine the effectiveness of point of care coagulation testing of prothrombin time to reduce the administration of FFP. Methods: Patient and assessor blind, single center randomized controlled parallel group trial in 220 patients aged between 18 and 90 years undergoing major surgery (any type, except cardiac surgery and liver transplant) with an estimated blood loss during surgery exceeding 20% of the calculated normal total blood volume or a requirement of FFP according to the judgment of treating surgeons or anesthesiologists. Patients will be randomized to usual care plus point of care coagulation testing or usual care alone without point of care testing. Primary endpoint will be the relative risk to receive any FFP peri-operatively. Significance: Point of care coagulation testing in the operation theatre may reduce the administration of fresh frozen plasma considerably, which in turn may decrease costs and complications usually associated with the administration of allogenic blood products.

Studietype

Intervensjonell

Registrering (Faktiske)

228

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Bern, Sveits, 3010
        • University Hospital Bern

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 90 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Age between 18 and 90 years
  • Major surgery
  • Estimated blood loss during surgery > 20% of individual blood volume of 70ml per kg body weight
  • Patients requiring FFP

Exclusion Criteria:

  • Known hereditary coagulopathy
  • Liver transplant
  • Cardiac surgery
  • Pregnancy
  • Preoperative hemoglobin <100g/l
  • Abnormal coagulation studies before surgery
  • Active treatment with drugs inhibiting coagulation or platelet function

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Kontroll
Standard pleie
Standard care
Eksperimentell: Intervention
Point of care monitoring used
Coagucheck XS Plus® is used for intraoperative measurement of Prothrombin time
Andre navn:
  • Coagucheck XS Plus® Roche Diagnostics, Basel, Switzerland

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
The relative risk to receive any FFP peri-operatively.
Tidsramme: at post-operative discharge from hospital, estimated to be about 5 days after randomisation
at post-operative discharge from hospital, estimated to be about 5 days after randomisation

Sekundære resultatmål

Resultatmål
Tidsramme
Number of units of FFP received between randomization and post-operative discharge from hospital
Tidsramme: at post-operative discharge from hospital, estimated to be about 5 days after randomisation
at post-operative discharge from hospital, estimated to be about 5 days after randomisation
The relative risk of major in-hospital bleeding defined as bleeding event requiring an extension of hospitalization, reoperation due to bleeding, bleeding resulting in hemorrhagic shock or death
Tidsramme: at post-operative discharge from hospital, estimated to be about 5 days after randomisation
at post-operative discharge from hospital, estimated to be about 5 days after randomisation
The relative risk of an APTC event (non-fatal myocardial infarction, non-fatal stroke, cardiovascular death, or death of unknown cause) between randomization and post-operative discharge from hospital
Tidsramme: at post-operative discharge from hospital, estimated to be about 5 days after randomisation
at post-operative discharge from hospital, estimated to be about 5 days after randomisation
The relative risk of overall mortality between randomization and post-operative discharge from hospital
Tidsramme: at post-operative discharge from hospital, estimated to be about 5 days after randomisation
at post-operative discharge from hospital, estimated to be about 5 days after randomisation

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Robert Greif, MD MME, Departement of Anesthesiology and Pain Therapy, Bern University Hospital
  • Hovedetterforsker: Natalie Urwyler, MD, Bern University Hospital
  • Studiestol: Peter Jüni, PD Dr med, CTU Bern, Bern University Hospital, and Institute of Social and Preventive Medicine, University of Bern

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mai 2008

Primær fullføring (Faktiske)

1. september 2011

Studiet fullført (Faktiske)

1. september 2011

Datoer for studieregistrering

Først innsendt

7. april 2008

Først innsendt som oppfylte QC-kriteriene

10. april 2008

Først lagt ut (Anslag)

11. april 2008

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

9. september 2015

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. september 2015

Sist bekreftet

1. september 2015

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • KEK 232_06
  • 232_06 (Annen identifikator: KEK)
  • 3200B0_122461 (Annet stipend/finansieringsnummer: SNF)
  • 1295 (Inselspital)

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere